World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
49307
World Ranking
9495
National Ranking
924

John P.H. Wilding publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John P.H. Wilding sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 505 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John P.H. Wilding D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John P.H. Wilding sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John P.H. Wilding is affiliated with the University of Liverpool in the United Kingdom. Their research focuses primarily on medicine, with significant contributions in biochemistry, genetics, and molecular biology. A considerable portion of their work is concentrated in the subfields of endocrinology, diabetes, and metabolism, as well as molecular biology, surgery, physiology, and pharmacology.

The scientist's main topics of research include diabetes treatment and management, metabolism in relation to diabetes and cancer, pharmacology and obesity treatment, pancreatic function and diabetes, diet and metabolism studies, diabetes management and research, and obesity and health practices.

Wilding's frequent co-authors include:

  • Deepak L. Bhatt
  • Marc S. Sabatine
  • Lawrence A. Leiter
  • Darren K. McGuire
  • Itamar Raz

They have published extensively in several venues, with the highest number of publications appearing in:

  • Diabetes Obesity and Metabolism
  • Circulation
  • Diabetes Care
  • Diabetes
  • BMJ Open

Among their recent papers are:

  • Once-Weekly Semaglutide in Adults with Overweight or Obesity, 2021, New England Journal of Medicine
  • Definition and diagnostic criteria of clinical obesity, 2025, The Lancet Diabetes & Endocrinology
  • Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension, 2022, Diabetes Obesity and Metabolism
  • Economic impacts of overweight and obesity: current and future estimates for 161 countries, 2022, BMJ Global Health
  • SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications, 2021, The Lancet

Best Publications

  • SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

    Thomas A Zelniker;Stephen D Wiviott;Itamar Raz;Kyungah Im

  • A role for glucagon-like peptide-1 in the central regulation of feeding

    M. D. Turton;D. O'Shea;I. Gunn;S. A. Beak

  • Once-Weekly Semaglutide in Adults with Overweight or Obesity.

    John P.H. Wilding;Rachel L. Batterham;Rachel L. Batterham;Salvatore Calanna;Melanie Davies

  • A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

    Xavier Pi-Sunyer;Arne Astrup;Ken Fujioka;Frank Greenway

  • Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation.

    G.A. Bray;K.K. Kim;J.P.H. Wilding

  • Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome

    Steven R Coughlin;Lynn Mawdsley;Julie A Mugarza;Peter M A Calverley

  • Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin

    Jan Bolinder;Östen Ljunggren;Joel Kullberg;Lars Johansson;Lars Johansson

  • Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

    Jay S. Skyler;George L. Bakris;Ezio Bonifacio;Tamara Darsow

  • Management of obesity

    George A Bray;Gema Frühbeck;Donna H Ryan;John P H Wilding

  • Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).

    Mikhail Kosiborod;Matthew A. Cavender;Alex Z. Fu;John P. Wilding

  • Food fails to suppress ghrelin levels in obese humans.

    P. J. English;M. A. Ghatei;I. A. Malik;S. R. Bloom

  • Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.

    Thomas A. Zelniker;Stephen D. Wiviott;Itamar Raz;KyungAh Im

  • 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

    Carel W le Roux;Carel W le Roux;Arne Astrup;Ken Fujioka;Frank Greenway

  • Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.

    Patrick M O'Neil;Andreas L Birkenfeld;Barbara McGowan;Ofri Mosenzon

  • Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.

    Ofri Mosenzon;Stephen D Wiviott;Avivit Cahn;Aliza Rozenberg

  • Anti-obesity drugs: past, present and future

    R. John Rodgers;Matthias H. Tschöp;John P. H. Wilding

  • Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.

    Eri T. Kato;Michael G. Silverman;Ofri Mosenzon;Thomas A. Zelniker

  • Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.

    Wilding Jp;Woo;Soler Ng;Pahor A

  • Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin.

    J. Bolinder;Östen Ljunggren;L. Johansson;L. Johansson;J. Wilding

  • A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers Applicability of a novel insulin-independent treatment

    John P.H. Wilding;Paul Norwood;Caroline T'joen;Arnaud Bastien

Frequent Co-Authors

Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Stephen D. Wiviott
Stephen D. Wiviott Brigham and Women's Hospital
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Itamar Raz
Itamar Raz Hebrew University of Jerusalem
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center
Frank L. Greenway
Frank L. Greenway Pennington Biomedical Research Center
Sabina A. Murphy
Sabina A. Murphy Brigham and Women's Hospital
Lawrence A. Leiter
Lawrence A. Leiter University of Toronto
M. A. Ghatei
M. A. Ghatei Imperial College London
Carel W. le Roux
Carel W. le Roux University College Dublin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering studying Medicine in the USA, there are several online degree options and career pathways that complement traditional medical studies. These programs are ideal for students seeking flexible schedules, lower costs, and diverse roles within the healthcare sector.

For those interested in medical administration, a low cost medical coding and billing online program offers a practical starting point. These programs equip students with essential skills to manage patient data, process insurance claims, and ensure the financial efficiency of healthcare facilities.

Nursing remains one of the most versatile healthcare professions. Aspiring nurses can choose from a range of affordable online nursing programs that lead to RN or BSN qualifications. Those wishing to advance their practice may consider the most affordable nurse practitioner programs, which train students to provide primary or specialized care.

For ambitious professionals aiming for leadership or research roles, pursuing postgraduate degrees like the cheapest dnp programs can open the door to advanced opportunities within healthcare systems and academia.

Best Scientists Citing John P.H. Wilding

Trending Scientists

Recently Published Articles